Sorrento Therapeutics, Inc.
Disulfide Bridging Conjugates
Last updated:
Abstract:
Provided are bispecific conjugates having the general formula: ##STR00001## pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and their use in the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
31 Aug 2020
Issue date:
25 Feb 2021